Skip to main content
. 2021 Dec 16;4(12):e2139550. doi: 10.1001/jamanetworkopen.2021.39550

Table 1. Baseline Patient Characteristics.

Characteristic Unmatched patients, No. (%) P value Propensity score–matched patients, No. (%) P value
Total (N = 542) EVT (n = 431) SMT (n = 111) Total (N = 304) EVT (n = 199) SMT (n = 105)
Age, median (IQR), y 65 (57-74) 64 (57-74) 66 (59-75) .15 65 (57-74) 64 (56-74) 66 (59-75) .21
Sex
Women 147 (27.1) 111 (25.8) 36 (32.4) .16 78 (25.7) 44 (22.1) 34 (32.4) .05
Men 395 (72.9) 320 (74.2) 75 (67.6) 226 (74.3) 155 (77.9) 71 (67.6)
NIHSS score, median (IQR) 30 (27-35) 30 (27-35) 32 (28-35) .17 32 (28-35) 32 (28-35) 32 (29-35) >.99
pc-ASPECTS, median (IQR)a 8 (6-9) 8 (6-9) 7 (6-8) .001 7 (6-8) 8 (6-8) 7 (6-8) .20
PC-CS, median (IQR) 4 (3-6) 4 (3-5) 4 (3.5-6) .05 4 (3-6) 4 (3-6) 4 (4-6) .26
BATMAN score, median (IQR) 4 (2-5) 3 (2-5) 4 (2-6) .008 4 (2-5) 3 (2-5) 4 (2-6) .01
Body temperature, median (IQR)b 36.7 (36.5-36.9) 36.7 (36.5-36.8) 36.7 (36.5-37.0) .02 36.6 (36.5-36.9) 36.6 (36.5-36.8) 36.7 (36.5-37.0) .06
SBP, median (IQR)c, mm Hg 151 (135-170) 150 (134-167) 160 (144-171) .001 151 (136-166) 147 (133-161) 160 (145-172) <.001
DBP level, median (IQR)c, mm Hg 85 (77-97) 85 (75-96) 88 (80-100) .05 85 (78-96) 84 (75-96) 87 (80-99) .09
Vascular risk factor
Smoking, current or past 179 (33.0) 160 (37.1) 19 (17.1) <.001 94 (30.9) 75 (37.7) 19 (18.1) <.001
Hypertension 388 (71.6) 308 (71.5) 80 (72.1) .90 213 (70.1) 137 (68.8) 76 (72.4) .52
Hyperlipidemia 173 (31.9) 133 (30.9) 40 (36.0) .30 103 (33.9) 65 (32.7) 38 (36.2) .54
Diabetes 128 (23.6) 103 (23.9) 25 (22.5) .76 69 (22.7) 47 (23.6) 22 (21.0) .60
Drinking, current or past 123 (22.7) 102 (23.7) 21 (18.9) .29 64 (21.1) 44 (22.1) 20 (19.0) .53
Medical history
Atrial fibrillation 120 (22.1) 104 (24.1) 16 (14.4) .03 59 (19.4) 43 (21.6) 16 (15.2) .18
Coronary artery disease 103 (19.0) 87 (20.1) 16 (14.4) .17 55 (18.1) 39 (19.6) 16 (15.2) .35
Heart failured 19 (3.5) 17 (3.9) 2 (1.8) .39 9 (3.0) 7 (3.5) 2 (1.9) .72
Prodrome 252 (46.5) 197 (45.7) 55 (49.5) .47 141 (46.4) 88 (44.2) 53 (50.5) .30
Cerebral infarction 134 (24.7) 101 (23.4) 33 (29.7) .17 78 (25.7) 49 (24.6) 29 (27.6) .57
Intracerebral hemorrhaged 10 (1.8) 8 (1.9) 2 (1.8) .97 4 (1.3) 2 (1.0) 2 (1.9) .61
Chronic bronchitisd 8 (1.5) 8 (1.9) 0 .37 5 (1.6) 5 (2.5) 0 (0) .17
Stroke etiology
LAA 339 (62.5) 268 (62.2) 71 (64.0) .004 196 (64.5) 129 (64.8) 67 (63.8) .25
CE 143 (26.4) 123 (28.5) 20 (18.0) 68 (22.4) 48 (24.1) 20 (19.0)
Other causes 60 (11.1) 40 (9.3) 20 (18.0) 40 (13.2) 22 (11.1) 18 (17.1)
Occlusion site
Distal BA 188 (34.7) 155 (36.0) 33 (29.7) .04 90 (29.6) 60 (30.2) 30 (28.6) .93
Middle BA 175 (32.3) 117 (27.1) 58 (52.3) 158 (52.0) 102 (51.3) 56 (53.3)
Proximal BA 76 (14.0) 70 (16.2) 6 (5.4) 15 (4.9) 9 (4.5) 6 (5.7)
VA-V4 103 (19.0) 89 (20.7) 14 (12.6) 41 (13.5) 28 (14.1) 13 (12.4)
IVT 131 (24.2) 93 (21.8) 38 (34.2) .009 88 (28.9) 57 (28.6) 31 (29.5) .87
OTT, median (IQR), min 311 (141-402) 308 (144-401) 244 (140-451) .75 235 (132-393) 233 (132-373) 244 (138-458) .34
Recanalization 350 (64.6) 341 (79.1) 9 (8.1) <.001 162 (53.3) 154 (77.4) 8 (7.6) <.001

Abbreviations: BA, basilar artery; BATMAN, basilar artery on tomography angiography; CE, cardioembolism; DBP, diastolic blood pressure; EVT, endovascular therapy; IVT, intravenous thrombolysis; LAA, large artery atherosclerosis; NIHSS, National Institutes of Health Stroke Scale; OTT, onset treatment time; pc-ASPECTS, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score; PC-CS, posterior circulation collateral score; SBP, systolic blood pressure; SMT, standard medical treatment; VA-V4, vertebral artery V4 segment.

a

Data were missing for 4 patients in the EVT group and 2 patients in the SMT group.

b

Data were missing for 6 patients in the EVT group and 1 patient in the SMT group.

c

Data were missing for 2 patients in the EVT group.

d

P values were calculated using Fisher exact tests.